Brief: Hamlet Pharma Q2 Loss Before Tax Narrows To SEK 2.8 Mln
26/02/2021 07:42
Feb 26 (Reuters) - Hamlet Pharma AB HAMLET.TE :
* Q2 LOSS BEFORE TAX AMOUNTED TO KSEK -2,828 (-7,986)
* REVENUE FOR Q2 TOTALED KSEK 0 (0)
Source text for Eikon: ID:nWkr8BS9vD
Further company coverage: HAMLET.TE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Hamlet BioPharma AB
See all newsBrief: Hamlet Biopharma Announces Completion Of Alpha1h Phase Ii Study In Non-Muscle Invasive Bladder Cancer
Brief: Hamlet Biopharma Holds Successful In Person Meeting With US FDA
Brief: Hamlet Pharma Q2 Loss Before Tax Narrows To SEK 2.8 Mln
Brief: Hamlet Pharma Gets Patent In Europe
Brief: Hamlet Pharma Gets Patent Granted In Europe